CLINICAL_TRIALS
trial_result
· 2026-04-23
Clinical Trial Update: Denosumab (DMAB) Discontinuation And Switching In Glucocorticoid-Induced Osteoporosis (GIOP): A Pilot Study [Phase 4]
Summary
A Phase 4 pilot study evaluating discontinuation and switching strategies for denosumab in glucocorticoid-induced osteoporosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2026-04-23